Skip to main content
Clinical Trials/NCT00537693
NCT00537693CompletedNot Applicable

Cytokine Removal by CRRT in Pediatric Sepsis: A Comparison of Convection Versus Diffusion

Sunnybrook Health Sciences Centre5 sites in 1 country40 target enrollmentStarted: September 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
5
Primary Endpoint
A 25% additional decrease in IL-6 concentration change

Study Overview

Brief Summary

This pilot study will compare the effect of diffusive versus convective Continuous Renal Replacement Therapy (CRRT) in children with sepsis who require CRRT.

The hypothesis for the study is that convective forms of CRRT provide enhanced clearance of cytokines and improved clinical responses as compared to a diffusive CRRT modality.

Detailed Description

The purpose of this study is to test the hypothesis that convective forms of Continuous Renal Replacement Therapy (CRRT) provides enhanced clearance of cytokines compared to a diffusive CRRT modality. Also, we plan to test the hypothesis that patients who receive convective CRRT modalities demonstrate improved clinical responses to patients who receive a diffusive CRRT modality.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
1 Year to 21 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with documented sepsis or suspected SIRS
  • •Patients initiating CRRT
  • •Age 1 to 21 years

Exclusion Criteria

  • •Patients on ECMO
  • •Patients receiving concomitant plasma exchange
  • •Cardiopulmonary bypass procedure within 96 hours of CRRT
  • •Patients with new onset acute leukemia
  • •Patients with active autoimmune disease
  • •Ungrafted stem cell transplant recipients

Arms & Interventions

1

Active Comparator

CRRT via Convection

Intervention: Continuous Renal Replacement Therapy (Procedure)

2

Active Comparator

CRRT via Diffusion

Intervention: Continuous Renal Replacement Therapy (Procedure)

Outcomes

Primary Outcomes

A 25% additional decrease in IL-6 concentration change

Time Frame: The First 24 hours of CRRT

Secondary Outcomes

  • Other cytokine removal rates(First 24 hours of CRRT)
  • Cytokine absorption on the CRRT membrane(First 24 hours of CRRT)
  • Hemodynamic parameters(First 24 hours of CRRT)
  • Changes in serum cytokine concentrations and clearance(After crossover, from 24-48 hours)
  • Changes in serum cytokine concentrations(From beginning to end of the study, independent of modality)

Investigators

Sponsor Class
Other

Study Sites (5)

Loading locations...

Similar Trials

Cytokine Removal by CRRT in Pediatric... | Clinical Trial